These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

90 related items for PubMed ID: 580447

  • 1. Distribution and pharmacokinetics of methotrexate in localized chemotherapy of solid Gardner's lymphosarcoma.
    Slavíková V, Motycka K, Slavík K, Spacek P, Cihar R, Balcarová A.
    Neoplasma; 1978; 25(2):211-6. PubMed ID: 580447
    [Abstract] [Full Text] [Related]

  • 2. Treatment of solid Gardner lymphosarcoma with methotrexate sorbed on 2-hydroxyethylmethacrylate polymer in combination with leukovorin.
    Motycka K, Slavík K, Balcarbová A, Cihar R, Spacek P, Kubín M.
    Neoplasma; 1978; 25(2):217-25. PubMed ID: 306074
    [Abstract] [Full Text] [Related]

  • 3. Localized chemotherapy of Gardner's lymphosarcoma of C3H mice using combinations of carrier-sorbed antifolics and detoxicating tetrahydrofolates.
    Motycka K, Slavík K, Balcarová A, Spacek P, Kubín M.
    Czech Med; 1981; 4(1-2):14-24. PubMed ID: 6973453
    [Abstract] [Full Text] [Related]

  • 4. The chemotherapy of C3H mice bearing Gardner lymphosarcoma with bovine fibrinogen-methotrexate derivative.
    Motycka K, Slavík K, Dyr JE, Balcarová A, Vodrázka Z.
    Neoplasma; 1981; 28(1):3-10. PubMed ID: 6895104
    [Abstract] [Full Text] [Related]

  • 5. Effect of methotrexate sorbed on modified 2-hydroxyethylmethacrylate carriers in mice of C3H strain with a solid Gardner lymphosarcoma.
    Motycka K, Slavík, kocovská A, Cihar R, Spacek P, Kubín M.
    Neoplasma; 1977; 24(3):271-6. PubMed ID: 578291
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effect of free and bovine fibrinogen-bound methotrexate and dibromoaminopterin on the dissemination of solid Gardner lymphosarcoma.
    Motycka K, Dyr JE, Macáková A, Slavík K.
    Neoplasma; 1982; 29(2):197-204. PubMed ID: 6896744
    [Abstract] [Full Text] [Related]

  • 11. Effect of lipid vesicle (liposome) encapsulation of methotrexate on its chemotherapeutic efficacy in solid rodent tumors.
    Kosloski MJ, Rosen F, Milholland RJ, Papahadjopoulos D.
    Cancer Res; 1978 Sep; 38(9):2848-53. PubMed ID: 581069
    [No Abstract] [Full Text] [Related]

  • 12. Tissue pharmacokinetics, inhibition of DNA synthesis and tumor cell kill after high-dose methotrexate in murine tumor models.
    Sirotnak FM, Donsbach RC, Dorick DM, Moccio DM.
    Cancer Res; 1976 Dec; 36(12):4672-8. PubMed ID: 1000510
    [Abstract] [Full Text] [Related]

  • 13. [The effect of the time of methotrexate administration over 24 hours on the antitumor activity of the preparation, its concentration in the blood and in the tumor in Pliss' lymphosarcoma in rats].
    Efimov ML, Vasil'eva GS, Malysheva LA, Abdullin KA.
    Vopr Onkol; 1992 Dec; 38(9):1085-9. PubMed ID: 1300822
    [Abstract] [Full Text] [Related]

  • 14. Tumor and tissue distribution of a methotrexate-anti-EL4 immunoglobulin conjugate in EL4 lymphoma-bearing mice.
    Uadia P, Blair AH, Ghose T.
    Cancer Res; 1984 Oct; 44(10):4263-6. PubMed ID: 6467187
    [Abstract] [Full Text] [Related]

  • 15. The use of protein as a carrier of methotrexate for experimental cancer chemotherapy. V. Alternative method for preparation of serum albumin-methotrexate derivative.
    Bures L, Lichý A, Bostík J, Spundová M.
    Neoplasma; 1990 Oct; 37(3):225-31. PubMed ID: 2370913
    [Abstract] [Full Text] [Related]

  • 16. Effects of liposome dose and the presence of lymphosarcoma cells on blood clearance and tissue distribution of large unilamellar liposomes in mice.
    Ellens H, Morselt HW, Dontje BH, Kalicharan D, Hulstaert CE, Scherphof GL.
    Cancer Res; 1983 Jun; 43(6):2927-34. PubMed ID: 6687832
    [Abstract] [Full Text] [Related]

  • 17. Analysis of "early" thymidine/inosine protection as an adjunct to methotrexate therapy.
    Eleff M, Franks PE, Wampler GL, Collins JM, Goldman ID.
    Cancer Treat Rep; 1985 Jun; 69(7-8):867-74. PubMed ID: 2410122
    [Abstract] [Full Text] [Related]

  • 18. Application of anti-methotrexate Fab fragments for the optimization of intraperitoneal methotrexate therapy in a murine model of peritoneal cancer.
    Lobo ED, Balthasar JP.
    J Pharm Sci; 2005 Sep; 94(9):1957-64. PubMed ID: 16052545
    [Abstract] [Full Text] [Related]

  • 19. Population pharmacokinetics of methotrexate in the guinea pig.
    Schlatter J, Di Blasi-Bouvet S, Raynaud F, Cisternino S.
    Cell Mol Biol (Noisy-le-grand); 1999 May; 45(3):363-8. PubMed ID: 10386793
    [Abstract] [Full Text] [Related]

  • 20. Changes in metabolism, food and water intake of C3H mice following transplantation of Gardner lymphosarcoma (LSG).
    Bostík J, Vybíral S, Spundová M.
    Physiol Bohemoslov; 1988 May; 37(4):325-32. PubMed ID: 2973618
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.